Background: Magnetic resonance imaging (MRI) is the actual gold standard for the radiological diagnosis of diabetic foot osteomyelitis (DFO).
Materials and methods: MRI is not always available and many patients have contraindications. We evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT (AGS) in eight DFO patients who underwent MRI before.
Results: The goal was to have a better clinical view on the extent of bone infection and to ameliorate the surgical approach for DFO. However, this additional scintigraphy did not change anything in the clinical approach.
Conclusion: We shared our experience with AGS for clinical management of complex DFO cases.
Keywords: Anti-granulocyte SPECT/CT; clinical benefit; comparisons; diabetic foot; magnetic resonance imaging; osteomyelitis.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.